Clinical Effects of Botulinum Toxin A and Phenol Block on Gait in Children with Cerebral Palsy

American Journal of Physical Medicine and Rehabilitation

Volumn 83, Issue 4, 2004, Pages 284-291

  Wong, Alice M K ^a   Chen, Chia Ling ^a   Chen, Carl P C ^a   Chou, Shih Wei ^a   Chung, Chia Ying ^a   Chen, Max J L ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Botulinum toxin type A; Cerebral palsy; Gait; Phenol block; Spasticity

Indexed keywords

BOTULINUM TOXIN A; PHENOL;

ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; FALLING; FATIGUE; FEMALE; FEVER; FOOT; GAIT; GAIT DISORDER; HANDICAPPED CHILD; HUMAN; INJECTION PAIN; INJECTION SITE; LEG MUSCLE; LEG PAIN; MALAISE; MALE; MUSCLE CONTRACTION; MUSCLE WEAKNESS; PRESSURE; SPASTICITY; TREATMENT OUTCOME; URINE INCONTINENCE; URINE RETENTION;

BOTULINUM TOXIN TYPE A; CASE-CONTROL STUDIES; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; GAIT; HUMANS; INJECTIONS, INTRAMUSCULAR; LOWER EXTREMITY; MALE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; NEUROMUSCULAR BLOCKADE; PHENOL; TREATMENT OUTCOME;

EID: 1642320855     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PHM.0000118038.02326.CA     Document Type: Article

References (20)

1. Hagerg B, Hagerg G: Origins of cerebral palsy, in David TJ (ed): Recent Advances in Pediatrics, No. 11. London, Churchill Livingston, 1999, pp 67-83
2. Molnar GE: Cerebral palsy, in Molnar GE (ed): Pediatric Rehabilitation. Baltimore, Williams and Wilkins, 1985, pp 481-533
3. Gage JR: Clinics in Developmental Medicine, No. 121: Gait Analysis in Cerebral Palsy. Oxford, Mackeith Press, 1991
4. Carpenter EB, Seitz DG: Intramuscular alcohol as an aid in management of spastic cerebral palsy. Dev Med Child Neurol 1980;22:497-501
5. Carpenter EB: Role of nerve blocks in the foot and ankle in cerebral palsy: Therapeutic and diagnostic. Foot Ankle 1983;4:164-6
6. Reeves KD, Baker A: A mixed somatic peripheral nerve block for painful or intractable spasticity: A review of 30 years of use. Am J Phys Med Rehabil 1992;2:205-10
7. Koman LA, Mooney JF III, Smith BP: Management of cerebral palsy with botulinum-A toxin: Preliminary investigation. J Pediatr Orthop 1993;13:489-95
8. Calderon-Gonzalez R, Calderon-Sepulveda RF, Rincon-Reyes M: Botulinum toxin A in management of cerebral palsy. Pediatr Neurol 1994;10:284-8
9. Cosgrove AP, Corry IS, Graham HK: Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-96
10. Denislic M, Meh D: Botulinum toxin in the treatment of cerebral palsy. Neuropediatrics 1995;26:249-52
11. Yang TF, Chan RC, Chuang TY: Treatment of cerebral palsy with botulinum toxin: Evaluation with gross motor function measure. J Formosa Med Assoc 1999;98:832-6
12. Koman LA, Mooney JF III, Smith BP, et al: Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. J Pediatr Orthop 2000;20:108-15
13. Kirazli Y, On A, Kismali B, et al: Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: A randomized, double-blind trial. Am J Phys Med Rehabil 1998;77:510-5
14. Preis S, Klemms A, Miller K: Gait analysis by measuring ground reaction forces in children changes to an adaptive gait pattern between the ages of one and five years. Dev Med Child Neurol 1997;39:228-33
15. Bohannon RW, Smith MB: Interrater reliability on a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7
16. Wong AMK, Chen CL, Hong WH, et al: Motor control assessment for rhizotomy in cerebral palsy. Am J Phys Med Rehabil 2000;79:441-50
17. Hesse S, Lucke D, Malezic M: Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57:1321-4
18. Russman BS: Why, when, and how to treat spasticity in cerebral palsy including a discussion of the use of botulinum toxin. Int Pediatr 1997;12:230-3
19. Gracies JM, Simpson D: Neuromuscular blockers. Phys Med Rehabil Clin North Am 1999;10:357-83
20. Gracies JM, Weisz DJ, Yang BY, et al: Impact of botulinum toxin type A (BTX-A) dilution and endplate targeting technique in upper limb spasticity. Ann Neurol 2002;52:S87